Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05242419 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Huperzine A Injection in Reducing Postoperative Delirium in Elderly Patients Undergoing Non-cardiac Surgery

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated April 2, 2025 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Dec 31, 2024 to Nov 30, 2025
    • Study completion date: Jun 30, 2025 to Dec 30, 2025
    v4
  2. Primary completion date: Dec 31, 2023 to Dec 31, 2024
    • Study completion date: Dec 30, 2024 to Jun 30, 2025
    v3
  3. Trial status: Not Yet Recruiting to Recruitingv2 Show 5 more changesShow less
    • Primary completion date: Dec 31, 2022 to Dec 31, 2023
    • Start date changed from estimate of Feb 20, 2022 to Jun 10, 2022
    • Study sites: 0 to 1
    • Study completion date: Jun 30, 2023 to Dec 30, 2024
    • Collaborators expanded, about 7 words
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
To observe and study the clinical effect of Huperzine A Injection on reducing postoperative delirium in elderly patients undergoing non-cardiac surgery
Trial Details
NCT Number NCT05242419
Lead Sponsor Second Affiliated Hospital of Wenzhou Medical University
Collaborators: Affiliated Wenling Hospital of Wenzhou Medical University
Conditions
(from sponsor)		 Injection, Non-cardiac Surgery, Delirium in Old Age, Post Operative Delirium
Related terms Emergence Delirium
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov